173 related articles for article (PubMed ID: 22028223)
1. Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis.
Bustamante MF; Fissolo N; Río J; Espejo C; Costa C; Mansilla MJ; Lizasoain I; Moro MA; Carmen Edo M; Montalban X; Comabella M
Ann Neurol; 2011 Oct; 70(4):634-45. PubMed ID: 22028223
[TBL] [Abstract][Full Text] [Related]
2. Interferon receptor expression in multiple sclerosis patients.
Oliver B; Mayorga C; Fernández V; Leyva L; León A; Luque G; López JC; Tamayo JA; Pinto-Medel MJ; de Ramon E; Blanco E; Alonso A; Fernández O
J Neuroimmunol; 2007 Feb; 183(1-2):225-31. PubMed ID: 17188754
[TBL] [Abstract][Full Text] [Related]
3. Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis.
Gilli F; Valentino P; Caldano M; Granieri L; Capobianco M; Malucchi S; Sala A; Marnetto F; Bertolotto A
Neurology; 2008 Dec; 71(24):1940-7. PubMed ID: 18971450
[TBL] [Abstract][Full Text] [Related]
4. A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis.
Comabella M; Lünemann JD; Río J; Sánchez A; López C; Julià E; Fernández M; Nonell L; Camiña-Tato M; Deisenhammer F; Caballero E; Tortola MT; Prinz M; Montalban X; Martin R
Brain; 2009 Dec; 132(Pt 12):3353-65. PubMed ID: 19741051
[TBL] [Abstract][Full Text] [Related]
5. The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.
Lindquist S; Hassinger S; Lindquist JA; Sailer M
Mult Scler; 2011 Jul; 17(7):851-66. PubMed ID: 21561957
[TBL] [Abstract][Full Text] [Related]
6. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis.
Gavasso S; Gjertsen B; Anderssen E; Myhr K; Vedeler C
Mult Scler; 2012 Aug; 18(8):1116-24. PubMed ID: 22287540
[TBL] [Abstract][Full Text] [Related]
8. Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
Azoulay D; Mausner-Fainberg K; Urshansky N; Fahoum F; Karni A
J Neuroimmunol; 2009 Jun; 211(1-2):114-9. PubMed ID: 19419774
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
Byun E; Caillier SJ; Montalban X; Villoslada P; Fernández O; Brassat D; Comabella M; Wang J; Barcellos LF; Baranzini SE; Oksenberg JR
Arch Neurol; 2008 Mar; 65(3):337-44. PubMed ID: 18195134
[TBL] [Abstract][Full Text] [Related]
10. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
Reske D; Thomas AV; Petereit HF; Fink GR; Schroeter M
Neuroimmunomodulation; 2009; 16(6):385-91. PubMed ID: 19609087
[TBL] [Abstract][Full Text] [Related]
11. Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferon-beta treatment?
Drulovic J; Savic E; Pekmezovic T; Mesaros S; Stojsavljevic N; Dujmovic-Basuroski I; Kostic J; Vasic V; Mostarica Stojkovic M; Popadic D
J Neuroimmunol; 2009 Oct; 215(1-2):90-5. PubMed ID: 19695714
[TBL] [Abstract][Full Text] [Related]
12. Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis.
Wiesemann E; Deb M; Trebst C; Hemmer B; Stangel M; Windhagen A
Mult Scler; 2008 Mar; 14(2):166-76. PubMed ID: 17942524
[TBL] [Abstract][Full Text] [Related]
13. [Interferon -beta therapy in multiple sclerosis].
Satoh J
Nihon Rinsho; 2006 Jul; 64(7):1297-309. PubMed ID: 16838648
[TBL] [Abstract][Full Text] [Related]
14. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
15. Effect of anti-IFN{beta} antibodies on MRI lesions of MS patients in the BECOME study.
Pachner AR; Cadavid D; Wolansky L; Skurnick J
Neurology; 2009 Nov; 73(18):1485-92. PubMed ID: 19884576
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
17. T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients.
Satoh J; Nakanishi M; Koike F; Onoue H; Aranami T; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Saito T; Ohta M; Miyake S; Kanda T; Fukazawa T; Yamamura T
J Neuroimmunol; 2006 May; 174(1-2):108-18. PubMed ID: 16564577
[TBL] [Abstract][Full Text] [Related]
18. Absence of MxA induction by interferon beta in patients with MS reflects complete loss of bioactivity.
Hesse D; Sellebjerg F; Sorensen PS
Neurology; 2009 Aug; 73(5):372-7. PubMed ID: 19652141
[TBL] [Abstract][Full Text] [Related]
19. Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis.
Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Di Sapio A; Capobianco M; Bertolotto A
J Neuroimmunol; 2005 Jan; 158(1-2):195-203. PubMed ID: 15589054
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis.
Martínez-Rodríguez JE; López-Botet M; Munteis E; Rio J; Roquer J; Montalban X; Comabella M
Clin Immunol; 2011 Dec; 141(3):348-56. PubMed ID: 21992960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
